Stock Analyst Choice

The Healing Dose

With its growth story being scripted both within India & outside, Ajanta Pharma looks to continue its upward surge

Ajanta Pharma Ltd. (APL) is a small-cap specialty pharmaceutical company engaged in the development, manufacture and commercialisation of pharmaceutical products since 1973. The company employs over 3,200 people worldwide and its products are sold in over 30 countries. APL focuses on commercialising unique generic products and pioneering synergistic combination products in therapeutic areas of malaria, cardiology, dermatology, gastroenterology, musculoskeletal disorders, ophthalmology and respiratory system. In India, company’s main focus has been on specialty segments whereas simultaneous opening of new international markets has been the key growth driver for it over the years. The company also engages in contract research for leading multinational pharmaceutical companies to expand its revenue base. Strengths APL operates five state-of-the-art manufacturing facilities – four among these are in India while one is in Mauritius. One of these, located at Aurangabad, is approved by the US Food and Drug Administration and health authorities of Brazil and Colombi

This article was originally published on June 22, 2012.


Other Categories